What's new

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 15, Status: Authorised

May 23, 2025 - 18:55
 0
Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ifirmacombi, irbesarta...

Next Article

Human medicines European public assessment report (EPAR): Menveo, meningococcal ...

Related Posts

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

May 20, 2025  0

Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - September 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2025, 10:00 (CEST) to 18 September 2025, 11:00 (CEST)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0